# Pharmacogenomics of New Antiretrovirals

> **NCT02514369** · — · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 179 (actual)

## Conditions studied

- HIV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02514369
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2024-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02514369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02514369, "Pharmacogenomics of New Antiretrovirals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02514369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*